Cargando…

Zinc transporter 8 (ZnT8) autoantibody epitope specificity and affinity examined with recombinant ZnT8 variant proteins in specific ZnT8R and ZnT8W autoantibody-positive type 1 diabetes patients

Variant-specific zinc transporter 8 autoantibodies (ZnT8A) against either arginine (R) or tryptophan (W) at amino acid (aa) position 325 of the zinc transporter 8 (ZnT8) has been identified in type 1 diabetes (T1D) patients. Reciprocal cross-over tests revealed differences in half-maximal binding to...

Descripción completa

Detalles Bibliográficos
Autores principales: Skärstrand, H, Krupinska, E, Haataja, T J K, Vaziri-Sani, F, Lagerstedt, J O, Lernmark, Å
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4298399/
https://www.ncbi.nlm.nih.gov/pubmed/25178386
http://dx.doi.org/10.1111/cei.12448
_version_ 1782353265643487232
author Skärstrand, H
Krupinska, E
Haataja, T J K
Vaziri-Sani, F
Lagerstedt, J O
Lernmark, Å
author_facet Skärstrand, H
Krupinska, E
Haataja, T J K
Vaziri-Sani, F
Lagerstedt, J O
Lernmark, Å
author_sort Skärstrand, H
collection PubMed
description Variant-specific zinc transporter 8 autoantibodies (ZnT8A) against either arginine (R) or tryptophan (W) at amino acid (aa) position 325 of the zinc transporter 8 (ZnT8) has been identified in type 1 diabetes (T1D) patients. Reciprocal cross-over tests revealed differences in half-maximal binding to indicate variable affinity of patient ZnT8 autoantibodies. Insufficient recombinant ZnT8 variant proteins have precluded detailed analyses of ZnT8 autoantibody affinity. The aims in the present study were to (i) generate recombinant ZnT8R- and ZnT8W-aa275-369 proteins; (ii) test the ZnT8R- and ZnT8W-aa275-369 proteins in reciprocal competitive radiobinding assays (RBA) against ZnT8R- and ZnT8W-aa268-369 labelled with (35)S-methionine; and (iii) determine the specificity and affinity of sera specific for either ZnT8 arginine (R) or ZnT8 tryptophan (W) autoantibodies in newly diagnosed T1D patients. The results demonstrate, first, that it was possible to produce recombinant human MBP–ZnT8-aa275-369 protein purified to homogeneity for RBA reciprocal competition experiments. Secondly, high-titre ZnT8WA sera diluted to half maximal binding showed significant specificity for respective variants of either ZnT8R or ZnT8W. Thirdly, ZnT8WA-positive sera showed high affinity for ZnT8W compared to ZnT8RA for ZnT8R. These data demonstrate that T1D patients may have single amino acid-specific autoantibodies directed against either ZnT8R or ZnT8W and that the autoantibody affinity to the respective variant may be different. Further studies are needed to assess the mechanisms by which variant-specific ZnT8A of variable affinity develop and their possible role in the pathogenic process leading to the clinical onset of T1D.
format Online
Article
Text
id pubmed-4298399
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BlackWell Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-42983992016-01-31 Zinc transporter 8 (ZnT8) autoantibody epitope specificity and affinity examined with recombinant ZnT8 variant proteins in specific ZnT8R and ZnT8W autoantibody-positive type 1 diabetes patients Skärstrand, H Krupinska, E Haataja, T J K Vaziri-Sani, F Lagerstedt, J O Lernmark, Å Clin Exp Immunol Original Articles Variant-specific zinc transporter 8 autoantibodies (ZnT8A) against either arginine (R) or tryptophan (W) at amino acid (aa) position 325 of the zinc transporter 8 (ZnT8) has been identified in type 1 diabetes (T1D) patients. Reciprocal cross-over tests revealed differences in half-maximal binding to indicate variable affinity of patient ZnT8 autoantibodies. Insufficient recombinant ZnT8 variant proteins have precluded detailed analyses of ZnT8 autoantibody affinity. The aims in the present study were to (i) generate recombinant ZnT8R- and ZnT8W-aa275-369 proteins; (ii) test the ZnT8R- and ZnT8W-aa275-369 proteins in reciprocal competitive radiobinding assays (RBA) against ZnT8R- and ZnT8W-aa268-369 labelled with (35)S-methionine; and (iii) determine the specificity and affinity of sera specific for either ZnT8 arginine (R) or ZnT8 tryptophan (W) autoantibodies in newly diagnosed T1D patients. The results demonstrate, first, that it was possible to produce recombinant human MBP–ZnT8-aa275-369 protein purified to homogeneity for RBA reciprocal competition experiments. Secondly, high-titre ZnT8WA sera diluted to half maximal binding showed significant specificity for respective variants of either ZnT8R or ZnT8W. Thirdly, ZnT8WA-positive sera showed high affinity for ZnT8W compared to ZnT8RA for ZnT8R. These data demonstrate that T1D patients may have single amino acid-specific autoantibodies directed against either ZnT8R or ZnT8W and that the autoantibody affinity to the respective variant may be different. Further studies are needed to assess the mechanisms by which variant-specific ZnT8A of variable affinity develop and their possible role in the pathogenic process leading to the clinical onset of T1D. BlackWell Publishing Ltd 2015-02 2015-01-02 /pmc/articles/PMC4298399/ /pubmed/25178386 http://dx.doi.org/10.1111/cei.12448 Text en © 2014 British Society for Immunology http://creativecommons.org/licenses/by/3.0/ This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Skärstrand, H
Krupinska, E
Haataja, T J K
Vaziri-Sani, F
Lagerstedt, J O
Lernmark, Å
Zinc transporter 8 (ZnT8) autoantibody epitope specificity and affinity examined with recombinant ZnT8 variant proteins in specific ZnT8R and ZnT8W autoantibody-positive type 1 diabetes patients
title Zinc transporter 8 (ZnT8) autoantibody epitope specificity and affinity examined with recombinant ZnT8 variant proteins in specific ZnT8R and ZnT8W autoantibody-positive type 1 diabetes patients
title_full Zinc transporter 8 (ZnT8) autoantibody epitope specificity and affinity examined with recombinant ZnT8 variant proteins in specific ZnT8R and ZnT8W autoantibody-positive type 1 diabetes patients
title_fullStr Zinc transporter 8 (ZnT8) autoantibody epitope specificity and affinity examined with recombinant ZnT8 variant proteins in specific ZnT8R and ZnT8W autoantibody-positive type 1 diabetes patients
title_full_unstemmed Zinc transporter 8 (ZnT8) autoantibody epitope specificity and affinity examined with recombinant ZnT8 variant proteins in specific ZnT8R and ZnT8W autoantibody-positive type 1 diabetes patients
title_short Zinc transporter 8 (ZnT8) autoantibody epitope specificity and affinity examined with recombinant ZnT8 variant proteins in specific ZnT8R and ZnT8W autoantibody-positive type 1 diabetes patients
title_sort zinc transporter 8 (znt8) autoantibody epitope specificity and affinity examined with recombinant znt8 variant proteins in specific znt8r and znt8w autoantibody-positive type 1 diabetes patients
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4298399/
https://www.ncbi.nlm.nih.gov/pubmed/25178386
http://dx.doi.org/10.1111/cei.12448
work_keys_str_mv AT skarstrandh zinctransporter8znt8autoantibodyepitopespecificityandaffinityexaminedwithrecombinantznt8variantproteinsinspecificznt8randznt8wautoantibodypositivetype1diabetespatients
AT krupinskae zinctransporter8znt8autoantibodyepitopespecificityandaffinityexaminedwithrecombinantznt8variantproteinsinspecificznt8randznt8wautoantibodypositivetype1diabetespatients
AT haatajatjk zinctransporter8znt8autoantibodyepitopespecificityandaffinityexaminedwithrecombinantznt8variantproteinsinspecificznt8randznt8wautoantibodypositivetype1diabetespatients
AT vazirisanif zinctransporter8znt8autoantibodyepitopespecificityandaffinityexaminedwithrecombinantznt8variantproteinsinspecificznt8randznt8wautoantibodypositivetype1diabetespatients
AT lagerstedtjo zinctransporter8znt8autoantibodyepitopespecificityandaffinityexaminedwithrecombinantznt8variantproteinsinspecificznt8randznt8wautoantibodypositivetype1diabetespatients
AT lernmarka zinctransporter8znt8autoantibodyepitopespecificityandaffinityexaminedwithrecombinantznt8variantproteinsinspecificznt8randznt8wautoantibodypositivetype1diabetespatients